Endometriosis Treatment Industry Research Report 2023
Highlights
The global Endometriosis Treatment market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Endometriosis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for Endometriosis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of Endometriosis Treatment include Bayer, Abbott, Ferring, Xianju Pharma, AstraZeneca, Merck & Co, Takeda Pharmaceutical, Theramex and Livzon Pharmaceutical Group, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Endometriosis Treatment in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Hormonal Contraceptives, which accounted for % of the global market of Endometriosis Treatment in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Endometriosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endometriosis Treatment.
The Endometriosis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Endometriosis Treatment market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endometriosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Endometriosis Treatment type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Endometriosis Treatment are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Endometriosis Treatment segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Endometriosis Treatment market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Endometriosis Treatment market.
Endometriosis Treatment Segment by Distribution Channel
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Endometriosis Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endometriosis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Endometriosis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Endometriosis Treatment industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endometriosis Treatment.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Endometriosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
The global Endometriosis Treatment market is projected to reach US$ million by 2029 from an estimated US$ million in 2023, at a CAGR of % during 2024 and 2029.
North American market for Endometriosis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Asia-Pacific market for Endometriosis Treatment is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
The major global companies of Endometriosis Treatment include Bayer, Abbott, Ferring, Xianju Pharma, AstraZeneca, Merck & Co, Takeda Pharmaceutical, Theramex and Livzon Pharmaceutical Group, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for Endometriosis Treatment in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2024 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Hormonal Contraceptives, which accounted for % of the global market of Endometriosis Treatment in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2024 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Endometriosis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Endometriosis Treatment.
The Endometriosis Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Endometriosis Treatment market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Endometriosis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Bayer
- Abbott
- Ferring
- Xianju Pharma
- AstraZeneca
- Merck & Co
- Takeda Pharmaceutical
- Theramex
- Livzon Pharmaceutical Group
- Beijing Biote Pharmaceutical Co., ltd
Global markets are presented by Endometriosis Treatment type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Endometriosis Treatment are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Endometriosis Treatment segment by Type
- Hormonal Contraceptives
- Progesterone Replacement Therapy
- GnRHAnalogue
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Endometriosis Treatment market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Endometriosis Treatment market.
Endometriosis Treatment Segment by Distribution Channel
- Hospital
- Retail Pharmacy
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Endometriosis Treatment market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Endometriosis Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Endometriosis Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Endometriosis Treatment industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Endometriosis Treatment.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Endometriosis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Endometriosis Treatment by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Hormonal Contraceptives
1.2.3 Progesterone Replacement Therapy
1.2.4 GnRHAnalogue
2.3 Endometriosis Treatment by Distribution Channel
2.3.1 Market Value Comparison by Distribution Channel (2018 VS 2022 VS 2029)
2.3.2 Hospital
2.3.3 Retail Pharmacy
2.3.4 Others
2.4 Assumptions and Limitations
3 ENDOMETRIOSIS TREATMENT BREAKDOWN DATA BY TYPE
3.1 Global Endometriosis Treatment Historic Market Size by Type (2018-2023)
3.2 Global Endometriosis Treatment Forecasted Market Size by Type (2023-2028)
4 ENDOMETRIOSIS TREATMENT BREAKDOWN DATA BY DISTRIBUTION CHANNEL
4.1 Global Endometriosis Treatment Historic Market Size by Distribution Channel (2018-2023)
4.2 Global Endometriosis Treatment Forecasted Market Size by Distribution Channel (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Endometriosis Treatment Market Perspective (2018-2029)
5.2 Global Endometriosis Treatment Growth Trends by Region
5.2.1 Global Endometriosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Endometriosis Treatment Historic Market Size by Region (2018-2023)
5.2.3 Endometriosis Treatment Forecasted Market Size by Region (2024-2029)
5.3 Endometriosis Treatment Market Dynamics
5.3.1 Endometriosis Treatment Industry Trends
5.3.2 Endometriosis Treatment Market Drivers
5.3.3 Endometriosis Treatment Market Challenges
5.3.4 Endometriosis Treatment Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Endometriosis Treatment Players by Revenue
6.1.1 Global Top Endometriosis Treatment Players by Revenue (2018-2023)
6.1.2 Global Endometriosis Treatment Revenue Market Share by Players (2018-2023)
6.2 Global Endometriosis Treatment Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Endometriosis Treatment Head office and Area Served
6.4 Global Endometriosis Treatment Players, Product Type & Application
6.5 Global Endometriosis Treatment Players, Date of Enter into This Industry
6.6 Global Endometriosis Treatment Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Endometriosis Treatment Market Size (2018-2029)
7.2 North America Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Endometriosis Treatment Market Size by Country (2018-2023)
7.4 North America Endometriosis Treatment Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Endometriosis Treatment Market Size (2018-2029)
8.2 Europe Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Endometriosis Treatment Market Size by Country (2018-2023)
8.4 Europe Endometriosis Treatment Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Endometriosis Treatment Market Size (2018-2029)
9.2 Asia-Pacific Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Endometriosis Treatment Market Size by Country (2018-2023)
9.4 Asia-Pacific Endometriosis Treatment Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Endometriosis Treatment Market Size (2018-2029)
10.2 Latin America Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Endometriosis Treatment Market Size by Country (2018-2023)
10.4 Latin America Endometriosis Treatment Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Endometriosis Treatment Market Size (2018-2029)
11.2 Middle East & Africa Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Endometriosis Treatment Market Size by Country (2018-2023)
11.4 Middle East & Africa Endometriosis Treatment Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Endometriosis Treatment Introduction
11.1.4 Bayer Revenue in Endometriosis Treatment Business (2017-2022)
11.1.5 Bayer Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Endometriosis Treatment Introduction
11.2.4 Abbott Revenue in Endometriosis Treatment Business (2017-2022)
11.2.5 Abbott Recent Development
11.3 Ferring
11.3.1 Ferring Company Detail
11.3.2 Ferring Business Overview
11.3.3 Ferring Endometriosis Treatment Introduction
11.3.4 Ferring Revenue in Endometriosis Treatment Business (2017-2022)
11.3.5 Ferring Recent Development
11.4 Xianju Pharma
11.4.1 Xianju Pharma Company Detail
11.4.2 Xianju Pharma Business Overview
11.4.3 Xianju Pharma Endometriosis Treatment Introduction
11.4.4 Xianju Pharma Revenue in Endometriosis Treatment Business (2017-2022)
11.4.5 Xianju Pharma Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Detail
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Endometriosis Treatment Introduction
11.5.4 AstraZeneca Revenue in Endometriosis Treatment Business (2017-2022)
11.5.5 AstraZeneca Recent Development
11.6 Merck & Co
11.6.1 Merck & Co Company Detail
11.6.2 Merck & Co Business Overview
11.6.3 Merck & Co Endometriosis Treatment Introduction
11.6.4 Merck & Co Revenue in Endometriosis Treatment Business (2017-2022)
11.6.5 Merck & Co Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Detail
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Endometriosis Treatment Introduction
11.7.4 Takeda Pharmaceutical Revenue in Endometriosis Treatment Business (2017-2022)
11.7.5 Takeda Pharmaceutical Recent Development
11.8 Theramex
11.8.1 Theramex Company Detail
11.8.2 Theramex Business Overview
11.8.3 Theramex Endometriosis Treatment Introduction
11.8.4 Theramex Revenue in Endometriosis Treatment Business (2017-2022)
11.8.5 Theramex Recent Development
11.9 Livzon Pharmaceutical Group
11.9.1 Livzon Pharmaceutical Group Company Detail
11.9.2 Livzon Pharmaceutical Group Business Overview
11.9.3 Livzon Pharmaceutical Group Endometriosis Treatment Introduction
11.9.4 Livzon Pharmaceutical Group Revenue in Endometriosis Treatment Business (2017-2022)
11.9.5 Livzon Pharmaceutical Group Recent Development
11.10 Beijing Biote Pharmaceutical Co., ltd
11.10.1 Beijing Biote Pharmaceutical Co., ltd Company Detail
11.10.2 Beijing Biote Pharmaceutical Co., ltd Business Overview
11.10.3 Beijing Biote Pharmaceutical Co., ltd Endometriosis Treatment Introduction
11.10.4 Beijing Biote Pharmaceutical Co., ltd Revenue in Endometriosis Treatment Business (2017-2022)
11.10.5 Beijing Biote Pharmaceutical Co., ltd Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Endometriosis Treatment by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 Hormonal Contraceptives
1.2.3 Progesterone Replacement Therapy
1.2.4 GnRHAnalogue
2.3 Endometriosis Treatment by Distribution Channel
2.3.1 Market Value Comparison by Distribution Channel (2018 VS 2022 VS 2029)
2.3.2 Hospital
2.3.3 Retail Pharmacy
2.3.4 Others
2.4 Assumptions and Limitations
3 ENDOMETRIOSIS TREATMENT BREAKDOWN DATA BY TYPE
3.1 Global Endometriosis Treatment Historic Market Size by Type (2018-2023)
3.2 Global Endometriosis Treatment Forecasted Market Size by Type (2023-2028)
4 ENDOMETRIOSIS TREATMENT BREAKDOWN DATA BY DISTRIBUTION CHANNEL
4.1 Global Endometriosis Treatment Historic Market Size by Distribution Channel (2018-2023)
4.2 Global Endometriosis Treatment Forecasted Market Size by Distribution Channel (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Endometriosis Treatment Market Perspective (2018-2029)
5.2 Global Endometriosis Treatment Growth Trends by Region
5.2.1 Global Endometriosis Treatment Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Endometriosis Treatment Historic Market Size by Region (2018-2023)
5.2.3 Endometriosis Treatment Forecasted Market Size by Region (2024-2029)
5.3 Endometriosis Treatment Market Dynamics
5.3.1 Endometriosis Treatment Industry Trends
5.3.2 Endometriosis Treatment Market Drivers
5.3.3 Endometriosis Treatment Market Challenges
5.3.4 Endometriosis Treatment Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Endometriosis Treatment Players by Revenue
6.1.1 Global Top Endometriosis Treatment Players by Revenue (2018-2023)
6.1.2 Global Endometriosis Treatment Revenue Market Share by Players (2018-2023)
6.2 Global Endometriosis Treatment Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Endometriosis Treatment Head office and Area Served
6.4 Global Endometriosis Treatment Players, Product Type & Application
6.5 Global Endometriosis Treatment Players, Date of Enter into This Industry
6.6 Global Endometriosis Treatment Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Endometriosis Treatment Market Size (2018-2029)
7.2 North America Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Endometriosis Treatment Market Size by Country (2018-2023)
7.4 North America Endometriosis Treatment Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Endometriosis Treatment Market Size (2018-2029)
8.2 Europe Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Endometriosis Treatment Market Size by Country (2018-2023)
8.4 Europe Endometriosis Treatment Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Endometriosis Treatment Market Size (2018-2029)
9.2 Asia-Pacific Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Endometriosis Treatment Market Size by Country (2018-2023)
9.4 Asia-Pacific Endometriosis Treatment Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Endometriosis Treatment Market Size (2018-2029)
10.2 Latin America Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Endometriosis Treatment Market Size by Country (2018-2023)
10.4 Latin America Endometriosis Treatment Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Endometriosis Treatment Market Size (2018-2029)
11.2 Middle East & Africa Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Endometriosis Treatment Market Size by Country (2018-2023)
11.4 Middle East & Africa Endometriosis Treatment Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Bayer
11.1.1 Bayer Company Detail
11.1.2 Bayer Business Overview
11.1.3 Bayer Endometriosis Treatment Introduction
11.1.4 Bayer Revenue in Endometriosis Treatment Business (2017-2022)
11.1.5 Bayer Recent Development
11.2 Abbott
11.2.1 Abbott Company Detail
11.2.2 Abbott Business Overview
11.2.3 Abbott Endometriosis Treatment Introduction
11.2.4 Abbott Revenue in Endometriosis Treatment Business (2017-2022)
11.2.5 Abbott Recent Development
11.3 Ferring
11.3.1 Ferring Company Detail
11.3.2 Ferring Business Overview
11.3.3 Ferring Endometriosis Treatment Introduction
11.3.4 Ferring Revenue in Endometriosis Treatment Business (2017-2022)
11.3.5 Ferring Recent Development
11.4 Xianju Pharma
11.4.1 Xianju Pharma Company Detail
11.4.2 Xianju Pharma Business Overview
11.4.3 Xianju Pharma Endometriosis Treatment Introduction
11.4.4 Xianju Pharma Revenue in Endometriosis Treatment Business (2017-2022)
11.4.5 Xianju Pharma Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Detail
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Endometriosis Treatment Introduction
11.5.4 AstraZeneca Revenue in Endometriosis Treatment Business (2017-2022)
11.5.5 AstraZeneca Recent Development
11.6 Merck & Co
11.6.1 Merck & Co Company Detail
11.6.2 Merck & Co Business Overview
11.6.3 Merck & Co Endometriosis Treatment Introduction
11.6.4 Merck & Co Revenue in Endometriosis Treatment Business (2017-2022)
11.6.5 Merck & Co Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Detail
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Endometriosis Treatment Introduction
11.7.4 Takeda Pharmaceutical Revenue in Endometriosis Treatment Business (2017-2022)
11.7.5 Takeda Pharmaceutical Recent Development
11.8 Theramex
11.8.1 Theramex Company Detail
11.8.2 Theramex Business Overview
11.8.3 Theramex Endometriosis Treatment Introduction
11.8.4 Theramex Revenue in Endometriosis Treatment Business (2017-2022)
11.8.5 Theramex Recent Development
11.9 Livzon Pharmaceutical Group
11.9.1 Livzon Pharmaceutical Group Company Detail
11.9.2 Livzon Pharmaceutical Group Business Overview
11.9.3 Livzon Pharmaceutical Group Endometriosis Treatment Introduction
11.9.4 Livzon Pharmaceutical Group Revenue in Endometriosis Treatment Business (2017-2022)
11.9.5 Livzon Pharmaceutical Group Recent Development
11.10 Beijing Biote Pharmaceutical Co., ltd
11.10.1 Beijing Biote Pharmaceutical Co., ltd Company Detail
11.10.2 Beijing Biote Pharmaceutical Co., ltd Business Overview
11.10.3 Beijing Biote Pharmaceutical Co., ltd Endometriosis Treatment Introduction
11.10.4 Beijing Biote Pharmaceutical Co., ltd Revenue in Endometriosis Treatment Business (2017-2022)
11.10.5 Beijing Biote Pharmaceutical Co., ltd Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Distribution Channel (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Endometriosis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Endometriosis Treatment Revenue Market Share by Type (2018-2023)
Table 7. Global Endometriosis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Endometriosis Treatment Revenue Market Share by Type (2024-2029)
Table 9. Global Endometriosis Treatment Market Size by Distribution Channel (2018-2023) & (US$ Million)
Table 10. Global Endometriosis Treatment Revenue Market Share by Distribution Channel (2018-2023)
Table 11. Global Endometriosis Treatment Forecasted Market Size by Distribution Channel (2024-2029) & (US$ Million)
Table 12. Global Endometriosis Treatment Revenue Market Share by Distribution Channel (2024-2029)
Table 13. Global Endometriosis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Endometriosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Endometriosis Treatment Market Share by Region (2018-2023)
Table 16. Global Endometriosis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Endometriosis Treatment Market Share by Region (2024-2029)
Table 18. Endometriosis Treatment Market Trends
Table 19. Endometriosis Treatment Market Drivers
Table 20. Endometriosis Treatment Market Challenges
Table 21. Endometriosis Treatment Market Restraints
Table 22. Global Top Endometriosis Treatment Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Endometriosis Treatment Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Endometriosis Treatment Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Endometriosis Treatment, Headquarters and Area Served
Table 26. Global Endometriosis Treatment Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Endometriosis Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Endometriosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Endometriosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Endometriosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Endometriosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Endometriosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Endometriosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Endometriosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Endometriosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Endometriosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Endometriosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. Bayer Company Detail
Table 46. Bayer Business Overview
Table 47. Bayer Endometriosis Treatment Product
Table 48. Bayer Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 49. Bayer Recent Development
Table 50. Abbott Company Detail
Table 51. Abbott Business Overview
Table 52. Abbott Endometriosis Treatment Product
Table 53. Abbott Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 54. Abbott Recent Development
Table 55. Ferring Company Detail
Table 56. Ferring Business Overview
Table 57. Ferring Endometriosis Treatment Product
Table 58. Ferring Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 59. Ferring Recent Development
Table 60. Xianju Pharma Company Detail
Table 61. Xianju Pharma Business Overview
Table 62. Xianju Pharma Endometriosis Treatment Product
Table 63. Xianju Pharma Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 64. Xianju Pharma Recent Development
Table 65. AstraZeneca Company Detail
Table 66. AstraZeneca Business Overview
Table 67. AstraZeneca Endometriosis Treatment Product
Table 68. AstraZeneca Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 69. AstraZeneca Recent Development
Table 70. Merck & Co Company Detail
Table 71. Merck & Co Business Overview
Table 72. Merck & Co Endometriosis Treatment Product
Table 73. Merck & Co Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 74. Merck & Co Recent Development
Table 75. Takeda Pharmaceutical Company Detail
Table 76. Takeda Pharmaceutical Business Overview
Table 77. Takeda Pharmaceutical Endometriosis Treatment Product
Table 78. Takeda Pharmaceutical Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 79. Takeda Pharmaceutical Recent Development
Table 80. Theramex Company Detail
Table 81. Theramex Business Overview
Table 82. Theramex Endometriosis Treatment Product
Table 83. Theramex Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 84. Theramex Recent Development
Table 85. Livzon Pharmaceutical Group Company Detail
Table 86. Livzon Pharmaceutical Group Business Overview
Table 87. Livzon Pharmaceutical Group Endometriosis Treatment Product
Table 88. Livzon Pharmaceutical Group Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 89. Livzon Pharmaceutical Group Recent Development
Table 90. Beijing Biote Pharmaceutical Co., ltd Company Detail
Table 91. Beijing Biote Pharmaceutical Co., ltd Business Overview
Table 92. Beijing Biote Pharmaceutical Co., ltd Endometriosis Treatment Product
Table 93. Beijing Biote Pharmaceutical Co., ltd Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 94. Beijing Biote Pharmaceutical Co., ltd Recent Development
Table 95. Bayer Company Information
Table 96. Bayer Business Overview
Table 97. Bayer Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 98. Bayer Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 99. Bayer Recent Development
Table 100. Abbott Company Information
Table 101. Abbott Business Overview
Table 102. Abbott Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 103. Abbott Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 104. Abbott Recent Development
Table 105. Ferring Company Information
Table 106. Ferring Business Overview
Table 107. Ferring Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 108. Ferring Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 109. Ferring Recent Development
Table 110. Xianju Pharma Company Information
Table 111. Xianju Pharma Business Overview
Table 112. Xianju Pharma Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 113. Xianju Pharma Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 114. Xianju Pharma Recent Development
Table 115. AstraZeneca Company Information
Table 116. AstraZeneca Business Overview
Table 117. AstraZeneca Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 118. AstraZeneca Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 119. AstraZeneca Recent Development
Table 120. Merck & Co Company Information
Table 121. Merck & Co Business Overview
Table 122. Merck & Co Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 123. Merck & Co Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 124. Merck & Co Recent Development
Table 125. Takeda Pharmaceutical Company Information
Table 126. Takeda Pharmaceutical Business Overview
Table 127. Takeda Pharmaceutical Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 128. Takeda Pharmaceutical Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 129. Takeda Pharmaceutical Recent Development
Table 130. Theramex Company Information
Table 131. Theramex Business Overview
Table 132. Theramex Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 133. Theramex Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 134. Theramex Recent Development
Table 135. Livzon Pharmaceutical Group Company Information
Table 136. Livzon Pharmaceutical Group Business Overview
Table 137. Livzon Pharmaceutical Group Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 138. Livzon Pharmaceutical Group Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 139. Livzon Pharmaceutical Group Recent Development
Table 140. Beijing Biote Pharmaceutical Co., ltd Company Information
Table 141. Beijing Biote Pharmaceutical Co., ltd Business Overview
Table 142. Beijing Biote Pharmaceutical Co., ltd Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 143. Beijing Biote Pharmaceutical Co., ltd Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Distribution Channel (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global Endometriosis Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 6. Global Endometriosis Treatment Revenue Market Share by Type (2018-2023)
Table 7. Global Endometriosis Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 8. Global Endometriosis Treatment Revenue Market Share by Type (2024-2029)
Table 9. Global Endometriosis Treatment Market Size by Distribution Channel (2018-2023) & (US$ Million)
Table 10. Global Endometriosis Treatment Revenue Market Share by Distribution Channel (2018-2023)
Table 11. Global Endometriosis Treatment Forecasted Market Size by Distribution Channel (2024-2029) & (US$ Million)
Table 12. Global Endometriosis Treatment Revenue Market Share by Distribution Channel (2024-2029)
Table 13. Global Endometriosis Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 14. Global Endometriosis Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 15. Global Endometriosis Treatment Market Share by Region (2018-2023)
Table 16. Global Endometriosis Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 17. Global Endometriosis Treatment Market Share by Region (2024-2029)
Table 18. Endometriosis Treatment Market Trends
Table 19. Endometriosis Treatment Market Drivers
Table 20. Endometriosis Treatment Market Challenges
Table 21. Endometriosis Treatment Market Restraints
Table 22. Global Top Endometriosis Treatment Manufacturers by Revenue (US$ Million) & (2018-2023)
Table 23. Global Endometriosis Treatment Revenue Market Share by Manufacturers (2018-2023)
Table 24. Global Endometriosis Treatment Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 25. Global Key Players of Endometriosis Treatment, Headquarters and Area Served
Table 26. Global Endometriosis Treatment Manufacturers, Product Type & Application
Table 27. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 28. Global Endometriosis Treatment by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2022)
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. North America Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. North America Endometriosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Endometriosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 33. Europe Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 34. Europe Endometriosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 35. Europe Endometriosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 36. Asia-Pacific Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 37. Asia-Pacific Endometriosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 38. Asia-Pacific Endometriosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 39. Latin America Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 40. Latin America Endometriosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 41. Latin America Endometriosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 42. Middle East & Africa Endometriosis Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 43. Middle East & Africa Endometriosis Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 44. Middle East & Africa Endometriosis Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 45. Bayer Company Detail
Table 46. Bayer Business Overview
Table 47. Bayer Endometriosis Treatment Product
Table 48. Bayer Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 49. Bayer Recent Development
Table 50. Abbott Company Detail
Table 51. Abbott Business Overview
Table 52. Abbott Endometriosis Treatment Product
Table 53. Abbott Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 54. Abbott Recent Development
Table 55. Ferring Company Detail
Table 56. Ferring Business Overview
Table 57. Ferring Endometriosis Treatment Product
Table 58. Ferring Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 59. Ferring Recent Development
Table 60. Xianju Pharma Company Detail
Table 61. Xianju Pharma Business Overview
Table 62. Xianju Pharma Endometriosis Treatment Product
Table 63. Xianju Pharma Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 64. Xianju Pharma Recent Development
Table 65. AstraZeneca Company Detail
Table 66. AstraZeneca Business Overview
Table 67. AstraZeneca Endometriosis Treatment Product
Table 68. AstraZeneca Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 69. AstraZeneca Recent Development
Table 70. Merck & Co Company Detail
Table 71. Merck & Co Business Overview
Table 72. Merck & Co Endometriosis Treatment Product
Table 73. Merck & Co Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 74. Merck & Co Recent Development
Table 75. Takeda Pharmaceutical Company Detail
Table 76. Takeda Pharmaceutical Business Overview
Table 77. Takeda Pharmaceutical Endometriosis Treatment Product
Table 78. Takeda Pharmaceutical Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 79. Takeda Pharmaceutical Recent Development
Table 80. Theramex Company Detail
Table 81. Theramex Business Overview
Table 82. Theramex Endometriosis Treatment Product
Table 83. Theramex Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 84. Theramex Recent Development
Table 85. Livzon Pharmaceutical Group Company Detail
Table 86. Livzon Pharmaceutical Group Business Overview
Table 87. Livzon Pharmaceutical Group Endometriosis Treatment Product
Table 88. Livzon Pharmaceutical Group Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 89. Livzon Pharmaceutical Group Recent Development
Table 90. Beijing Biote Pharmaceutical Co., ltd Company Detail
Table 91. Beijing Biote Pharmaceutical Co., ltd Business Overview
Table 92. Beijing Biote Pharmaceutical Co., ltd Endometriosis Treatment Product
Table 93. Beijing Biote Pharmaceutical Co., ltd Revenue in Endometriosis Treatment Business (2017-2022) & (US$ Million)
Table 94. Beijing Biote Pharmaceutical Co., ltd Recent Development
Table 95. Bayer Company Information
Table 96. Bayer Business Overview
Table 97. Bayer Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 98. Bayer Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 99. Bayer Recent Development
Table 100. Abbott Company Information
Table 101. Abbott Business Overview
Table 102. Abbott Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 103. Abbott Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 104. Abbott Recent Development
Table 105. Ferring Company Information
Table 106. Ferring Business Overview
Table 107. Ferring Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 108. Ferring Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 109. Ferring Recent Development
Table 110. Xianju Pharma Company Information
Table 111. Xianju Pharma Business Overview
Table 112. Xianju Pharma Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 113. Xianju Pharma Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 114. Xianju Pharma Recent Development
Table 115. AstraZeneca Company Information
Table 116. AstraZeneca Business Overview
Table 117. AstraZeneca Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 118. AstraZeneca Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 119. AstraZeneca Recent Development
Table 120. Merck & Co Company Information
Table 121. Merck & Co Business Overview
Table 122. Merck & Co Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 123. Merck & Co Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 124. Merck & Co Recent Development
Table 125. Takeda Pharmaceutical Company Information
Table 126. Takeda Pharmaceutical Business Overview
Table 127. Takeda Pharmaceutical Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 128. Takeda Pharmaceutical Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 129. Takeda Pharmaceutical Recent Development
Table 130. Theramex Company Information
Table 131. Theramex Business Overview
Table 132. Theramex Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 133. Theramex Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 134. Theramex Recent Development
Table 135. Livzon Pharmaceutical Group Company Information
Table 136. Livzon Pharmaceutical Group Business Overview
Table 137. Livzon Pharmaceutical Group Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 138. Livzon Pharmaceutical Group Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
Table 139. Livzon Pharmaceutical Group Recent Development
Table 140. Beijing Biote Pharmaceutical Co., ltd Company Information
Table 141. Beijing Biote Pharmaceutical Co., ltd Business Overview
Table 142. Beijing Biote Pharmaceutical Co., ltd Endometriosis Treatment Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million)
Table 143. Beijing Biote Pharmaceutical Co., ltd Revenue in Endometriosis Treatment Business (2018-2023) & (US$ Million) Portfolio
